New offering furthers OFFFIELD’s mission to make daily active life enjoyable, helping athletes get out of their heads and get the most out of their bodies.
LOS ANGELES — Today, Athletic Cannabis company OFFFIELD announces a new innovation and category expansion, Athletic Gummies. Designed and formulated to provide a sustainable source of energy during exercise, combining the science of the “Runner’s High” with functional plant-based ingredients.
Cannabis Research Meets Athletic Performance
Athletic Gummies are a high strength alternative format to OFFFIELD’s popular Enhanced Hydration drink mix. Each serving of Athletic Gummies is formulated with 100mg of broad-spectrum CBD and 16mg of the rare cannabinoid CBG – free of additives, isolates, and impurities – to simulate the “Runner’s High” effect.
Cannabis research has uncovered that cannabinoids (not endorphins) are responsible for the effects of the Runner’s High. Uniquely capable of managing mood, inflammation, and pain relief – which endorphins were once held responsible for but now prove not to be. OFFFIELD’s products use these scientific findings as the foundation for their formulations.
The cannabinoids combine with Elderberry Raspberry superfruits and a precise array of active performance ingredients. Including 20mg of Yerba Caffeine, B Vitamins, Amino Acids, and Carbohydrates for sustainable energy and endurance; 35 mg of Vitamin C to slow down the processes that cause cell damage in the body, and electrolytes to aid in hydration and support fluid balance, collectively creating an optimal experience of joyful and improved movement.
“When it comes to long-distance running, one of the biggest drawbacks is having to carry water. It’s heavy and annoying,” said Tony Fur, Co-Founder of OFFFIELD “We wanted to deliver on the same benefits as our Enhanced Hydration but optimized for a higher dose given the rigor of the activity. So, we began experimenting with gummies.”
Building A Better Gummy
Athletic Gummies are a result of the company’s innovative Offfield Labs program. Through this initiative, OFFFIELD co-creates new products with their athlete community. The inaugural Offfield Labs project, Athletic Gummies, sold out in only 2 weeks. Over 200 athletes participated in the development surveying with a 98% approval rating.
“We found that endurance athletes regularly take multiple supplements, liquids, and synthetic painkillers. Our goal was to provide a compact, portable, and plant-based alternative,” said Dr. Mark Farber, MD, Ph.D., and Chief Scientific Officer at OFFFIELD. “Offfield Labs gave us a diverse test group ranging in age, location, and sports, to find the optimal blend that would work across disciplines. After analyzing the feedback, we successfully reformulated the gummy.”
Product Details and Pricing
OFFFIELD Athletic Gummies are sold in packs of 32 Elderberry Raspberry gummies for $52.00. Each order ships free. Subscribers enjoy a 25% discount ($39.00). The product is sold at www.offfield.com
About OFFFIELD
OFFFIELD is an Athletic Cannabis company founded to inspire ”active lives and active minds.” We call it Movement Made Happy.
Based in sunny and optimistic Los Angeles, we combine innovative cannabis research with performance science to create clean, effective, and natural products that keep everyday athletes moving happy through the benefits of the “Runners’ High”. 
- Nebraska medical cannabis backers file legal challenge to petition process
Supporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot. - N.J. lawmakers seek to curb cannabis use
As New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job. - Missouri House votes to require disclosure of medical cannabis ownership records
The Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view. - Nebraska medical cannabis group calls for ‘grassroots’ effort after losing donor
Unable to raise $1 million to replace funds from a major donor who died, Nebraskans for Medical Marijuana issued a plea Friday for supporters of the cause to take up petitions and gather signatures. - Lawmaker says GOP resistance may doom Missouri cannabis legalization
A Republican lawmaker pushing legislation to legalize recreational marijuana in Missouri says his bill is in jeopardy because of stall tactics by his GOP colleagues and the insistence of the House floor leader that it include license caps. - SD cannabis legalization campaign to submit signatures for November
Today, South Dakotans for Better Marijuana Laws, the political group that led the 2020 campaign to legalize cannabis in South Dakota, submitted petitions to place an adult-use cannabis legalization initiated measure on the November 2022 ballot. - NH senate votes down legal cannabis bills, ending chances for 2022
The New Hampshire Senate voted down two bills to legalize cannabis Thursday, likely heading off the last opportunities for legalization in the Granite State this year. - Last Prisoner Project: Taking Real Action to Help Cannabis Prisoners
“It really remains a fundamental injustice,” said Stephen Post, of America’s criminalization of cannabis. “We’re really helping to try to turn around those injustices.” Post works as a campaign manager for Last Prisoner Project (LPP), a nonprofit assisting cannabis prisoners. - Federal attempts to legalize cannabis flail, while public support grows
Across the country, attitudes toward cannabis are becoming more permissive and accepting, but partisan gridlock in Congress virtually ensures that legislation to decriminalize marijuana will languish and die in the U.S. Senate. - Wisconsin GOP medical cannabis bill gets 4/20 public hearing
The bill, authored by Sen. Mary Felzkowski (R-Irma), would legalize medicinal use of cannabis under specific conditions. Patients would need to be registered, and the cannabis must be in the form of a liquid, oil, pill, tincture or topical ointment.